129 related articles for article (PubMed ID: 31758938)
1. Cytostatic pharmaceuticals as water contaminants.
Jureczko M; Kalka J
Eur J Pharmacol; 2020 Jan; 866():172816. PubMed ID: 31758938
[TBL] [Abstract][Full Text] [Related]
2. Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain).
Franquet-Griell H; Gómez-Canela C; Ventura F; Lacorte S
Environ Res; 2015 Apr; 138():161-72. PubMed ID: 25721243
[TBL] [Abstract][Full Text] [Related]
3. Determination of cytostatic drugs in Besòs River (NE Spain) and comparison with predicted environmental concentrations.
Franquet-Griell H; Cornadó D; Caixach J; Ventura F; Lacorte S
Environ Sci Pollut Res Int; 2017 Mar; 24(7):6492-6503. PubMed ID: 28074365
[TBL] [Abstract][Full Text] [Related]
4. Ecotoxicity risk of presence of two cytostatic drugs: Bleomycin and vincristine and their binary mixture in aquatic environment.
Jureczko M; Przystaś W
Ecotoxicol Environ Saf; 2019 May; 172():210-215. PubMed ID: 30710771
[TBL] [Abstract][Full Text] [Related]
5. Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?
Besse JP; Latour JF; Garric J
Environ Int; 2012 Feb; 39(1):73-86. PubMed ID: 22208745
[TBL] [Abstract][Full Text] [Related]
6. New insights on cytostatic drug risk assessment in aquatic environments based on measured concentrations in surface waters.
Gouveia TIA; Alves A; Santos MSF
Environ Int; 2019 Dec; 133(Pt B):105236. PubMed ID: 31675568
[TBL] [Abstract][Full Text] [Related]
7. Contributions towards the hazard evaluation of two widely used cytostatic drugs.
Monteiro B; Venâncio C; Francisco R; Sousa ACA; Lopes I
Environ Sci Pollut Res Int; 2023 Feb; 30(6):15641-15654. PubMed ID: 36169838
[TBL] [Abstract][Full Text] [Related]
8. Ecotoxicology of human pharmaceuticals.
Fent K; Weston AA; Caminada D
Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
[TBL] [Abstract][Full Text] [Related]
9. Are cytostatic drugs in surface waters a potential threat?
Gouveia TIA; Mota IH; Silva AMT; Alves A; Santos MSF
Sci Total Environ; 2022 Dec; 853():158559. PubMed ID: 36087660
[TBL] [Abstract][Full Text] [Related]
10. Liquid-liquid extraction as a simple tool to quickly quantify fourteen cytostatics in urban wastewaters and access their impact in aquatic biota.
Gouveia TIA; Silva AMT; Ribeiro AR; Alves A; Santos MSF
Sci Total Environ; 2020 Oct; 740():139995. PubMed ID: 32559532
[TBL] [Abstract][Full Text] [Related]
11. Anticancer drugs in the aquatic ecosystem: Environmental occurrence, ecotoxicological effect and risk assessment.
Li D; Chen H; Liu H; Schlenk D; Mu J; Lacorte S; Ying GG; Xie L
Environ Int; 2021 Aug; 153():106543. PubMed ID: 33813231
[TBL] [Abstract][Full Text] [Related]
12. Toxicity toward freshwater and marine water organisms of the cytostatic drugs bleomycin and vincristine and their binary mixture.
Jureczko M; Przystaś W
Sci Total Environ; 2024 Jul; 933():173175. PubMed ID: 38750736
[TBL] [Abstract][Full Text] [Related]
13. Threat and sustainable technological solution for antineoplastic drugs pollution: Review on a persisting global issue.
Yadav A; Rene ER; Mandal MK; Dubey KK
Chemosphere; 2021 Jan; 263():128285. PubMed ID: 33297229
[TBL] [Abstract][Full Text] [Related]
14. Drugs of abuse, cytostatic drugs and iodinated contrast media in tap water from the Madrid region (central Spain):A case study to analyse their occurrence and human health risk characterization.
Mendoza A; Zonja B; Mastroianni N; Negreira N; López de Alda M; Pérez S; Barceló D; Gil A; Valcárcel Y
Environ Int; 2016 Jan; 86():107-18. PubMed ID: 26571428
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic toxicity of six anticancer drugs on rotifers and crustaceans.
Parrella A; Lavorgna M; Criscuolo E; Russo C; Fiumano V; Isidori M
Chemosphere; 2014 Nov; 115():59-66. PubMed ID: 24512989
[TBL] [Abstract][Full Text] [Related]
16. Removal of cytostatic drugs from aquatic environment: a review.
Zhang J; Chang VW; Giannis A; Wang JY
Sci Total Environ; 2013 Feb; 445-446():281-98. PubMed ID: 23337605
[TBL] [Abstract][Full Text] [Related]
17. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on the occurrence of cytostatic drugs in hospital effluents in Beijing, China.
Yin J; Shao B; Zhang J; Li K
Bull Environ Contam Toxicol; 2010 Jan; 84(1):39-45. PubMed ID: 19795089
[TBL] [Abstract][Full Text] [Related]
19. Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater.
Lenz K; Mahnik SN; Weissenbacher N; Mader RM; Krenn P; Hann S; Koellensperger G; Uhl M; Knasmüller S; Ferk F; Bursch W; Fuerhacker M
Water Sci Technol; 2007; 56(12):141-9. PubMed ID: 18075190
[TBL] [Abstract][Full Text] [Related]
20. A case study to identify priority cytostatic contaminants in hospital effluents.
Olalla A; Negreira N; López de Alda M; Barceló D; Valcárcel Y
Chemosphere; 2018 Jan; 190():417-430. PubMed ID: 29024886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
